Atomistry » Chlorine » PDB 5nkc-5nru » 5nkg
Atomistry »
  Chlorine »
    PDB 5nkc-5nru »
      5nkg »

Chlorine in PDB 5nkg: Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D

Enzymatic activity of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D

All present enzymatic activity of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D:
2.7.10.1;

Protein crystallography data

The structure of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D, PDB code: 5nkg was solved by D.Kudlinzki, V.L.Linhard, K.Witt, S.L.Gande, K.Saxena, S.Heinzlmeir, G.Medard, B.Kuester, H.Schwalbe, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 29.11 / 1.10
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 32.736, 107.202, 40.471, 90.00, 108.75, 90.00
R / Rfree (%) 17.2 / 19

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D (pdb code 5nkg). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D, PDB code: 5nkg:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 5nkg

Go back to Chlorine Binding Sites List in 5nkg
Chlorine binding site 1 out of 2 in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1001

b:13.4
occ:0.55
CL A:8ZK1001 0.0 13.4 0.6
CBE A:8ZK1001 0.3 13.2 0.5
CBD A:8ZK1001 1.6 12.8 0.5
CAB A:8ZK1001 1.8 12.8 0.6
CAC A:8ZK1001 2.6 10.7 0.5
CBF A:8ZK1001 2.7 14.9 0.5
CBH A:8ZK1001 2.7 15.1 0.6
CAC A:8ZK1001 2.7 10.3 0.6
NAD A:8ZK1001 2.9 10.7 0.5
NAD A:8ZK1001 3.0 10.4 0.6
CAE A:8ZK1001 3.3 9.6 0.5
CAE A:8ZK1001 3.3 9.3 0.6
OBC A:8ZK1001 3.3 10.7 0.6
OBC A:8ZK1001 3.4 10.8 0.5
O A:HOH1131 3.5 22.1 1.0
CB A:SER756 3.6 14.1 1.0
O A:HOH1324 3.8 28.1 1.0
CAB A:8ZK1001 3.9 12.0 0.5
CBG A:8ZK1001 4.0 15.4 0.5
O A:HOH1302 4.0 20.3 1.0
CD1 A:LEU746 4.0 9.5 1.0
CBG A:8ZK1001 4.0 15.3 0.6
CBD A:8ZK1001 4.1 11.9 0.6
CG2 A:ILE676 4.2 11.4 0.7
OG A:SER756 4.2 15.5 1.0
CAF A:8ZK1001 4.2 8.8 0.5
CG1 A:ILE676 4.2 10.3 0.7
CG2 A:ILE676 4.2 19.6 0.3
CAF A:8ZK1001 4.3 8.9 0.6
O A:HOH1212 4.3 15.8 1.0
CG1 A:ILE676 4.4 6.2 0.3
CBH A:8ZK1001 4.5 11.8 0.5
N A:ASP757 4.5 9.3 1.0
O A:HOH1245 4.5 18.8 1.0
CBF A:8ZK1001 4.6 11.6 0.6
CB A:ILE676 4.6 10.2 0.3
CB A:ILE676 4.6 7.5 0.7
CA A:SER756 4.7 9.5 1.0
CD1 A:ILE676 4.8 14.2 0.7
OE2 A:GLU663 4.8 13.3 1.0
CAG A:8ZK1001 4.8 9.7 0.5
CAG A:8ZK1001 4.9 9.5 0.6
SD A:MET667 4.9 31.8 1.0
CG2 A:THR692 5.0 10.8 1.0

Chlorine binding site 2 out of 2 in 5nkg

Go back to Chlorine Binding Sites List in 5nkg
Chlorine binding site 2 out of 2 in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Compound 3D within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1001

b:13.7
occ:0.45
CL A:8ZK1001 0.0 13.7 0.5
CBE A:8ZK1001 0.3 13.2 0.6
CBD A:8ZK1001 1.6 11.9 0.6
CAB A:8ZK1001 1.7 12.0 0.5
CBF A:8ZK1001 2.6 11.6 0.6
CAC A:8ZK1001 2.6 10.3 0.6
CBH A:8ZK1001 2.7 11.8 0.5
CAC A:8ZK1001 2.7 10.7 0.5
NAD A:8ZK1001 3.0 10.4 0.6
NAD A:8ZK1001 3.0 10.7 0.5
O A:ALA644 3.3 11.5 1.0
C A:ALA644 3.5 11.0 1.0
O A:ILE690 3.5 12.3 1.0
N A:LYS646 3.5 12.2 1.0
N A:ILE645 3.6 12.3 1.0
CB A:ALA644 3.7 13.2 1.0
OG1 A:THR692 3.7 10.6 1.0
CAE A:8ZK1001 3.7 9.3 0.6
CAE A:8ZK1001 3.7 9.6 0.5
C A:ILE645 3.7 13.3 1.0
CA A:ILE645 3.8 12.7 1.0
CB A:LYS646 3.8 13.5 1.0
CBG A:8ZK1001 3.9 15.3 0.6
CG2 A:THR692 3.9 10.8 1.0
CAB A:8ZK1001 3.9 12.8 0.6
CBG A:8ZK1001 4.0 15.4 0.5
CBD A:8ZK1001 4.0 12.8 0.5
OBC A:8ZK1001 4.1 10.8 0.5
OBC A:8ZK1001 4.1 10.7 0.6
N A:THR692 4.2 10.8 1.0
CA A:ALA644 4.2 11.8 1.0
CA A:LYS646 4.3 12.5 1.0
C A:ILE690 4.3 11.2 1.0
CB A:THR692 4.3 10.6 1.0
CBH A:8ZK1001 4.4 15.1 0.6
O A:ILE645 4.5 14.9 1.0
CBF A:8ZK1001 4.5 14.9 0.5
CAF A:8ZK1001 4.7 8.8 0.5
CAF A:8ZK1001 4.7 8.9 0.6
CG1 A:VAL627 4.7 18.8 1.0
CA A:ILE691 4.8 11.5 1.0
C A:ILE691 4.8 11.2 1.0
CG2 A:ILE690 4.8 13.4 1.0
O A:HOH1302 4.9 20.3 1.0
N A:ILE691 4.9 11.4 1.0
CA A:THR692 4.9 10.4 1.0
CB A:ILE690 5.0 11.1 1.0

Reference:

S.Heinzlmeir, J.Lohse, T.Treiber, D.Kudlinzki, V.Linhard, S.L.Gande, S.Sreeramulu, K.Saxena, X.Liu, M.Wilhelm, H.Schwalbe, B.Kuster, G.Medard. Chemoproteomics-Aided Medicinal Chemistry For the Discovery of EPHA2 Inhibitors. Chemmedchem V. 12 999 2017.
ISSN: ESSN 1860-7187
PubMed: 28544567
DOI: 10.1002/CMDC.201700217
Page generated: Sat Dec 12 12:09:54 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy